Results 11 to 20 of about 3,173,890 (267)
Inhibition of Hepatic Acetyl Coenzyme A Carboxylase by Hypolipidemic Agents
Abstract The effects of two hypolipidemic agents, 2-methyl-2-[p-(1,2,3,4-tetrahydro-1-naphthyl)-phenoxy]propionate and ethyl 2-(p-chlorophenyl)-2-methylpropionate, on the activity of a highly purified preparation of acetyl coenzyme A carboxylase, obtained from chicken livers, were studied.
Michael E. Maragoudakis
openalex +4 more sources
Background: Data on the extent of use and costs of lipid-lowering agents are not widely available. Our aim was to study the drug utilization and morbidity pattern, cost of different hypolipidemic drugs along with the risk assessment for coronary heart ...
Kamlesh Patel+5 more
openalex +3 more sources
Antihyperglycemic and Hypolipidemic Activities of Flavonoids Isolated from Smilax Dominguensis Mediated by Peroxisome Proliferator-Activated Receptors [PDF]
Background/objetives: Mexican people use Smilax dominguensis as a traditional medicine for diabetes control. Some reports have shown an anti-hyperglycemic effect in animal models.
Erandi Ortiz-Barragán+9 more
doaj +2 more sources
Introduction: To solve the problem of complex and safe pharmacological correction of metabolic disorders, including hyperlipidemia, hyperglycemia, and liver lesions is currently very important. With this in mind, the new derivatives of cyanothioacetamide
Elena S. Ketova+3 more
doaj +2 more sources
A Proof-of-Concept for a Hypolipidemic Brown Trout Model [PDF]
The impacts of hypolipidemic pharmaceuticals on fish lipid metabolism remain unexplored. However, data points to similar effects and mechanisms of action between fish and humans.
Tiago Lourenço+4 more
doaj +2 more sources
Enhanced Myopathy Following Administration of Hypolipidemic Agents under Urethane Anesthesia.
The enhanced effect of urethane anesthesia on the serum creatine kinase (CPK) level following administration of hypolipidemic agents was examined to develop a convenient experimental screening method for drug-induced myopathy.
Aki NAKAI+4 more
openalex +3 more sources
Are We Using Ezetimibe As Much As We Should? [PDF]
Lipid-lowering therapies, particularly non-statin regimens, are underutilized as ~2/3 of patients with atherosclerotic cardiovascular (CV) disease (CVD) are not optimally managed, and do not attain target low-density lipoprotein cholesterol (LDL-C ...
Antonis A Manolis+3 more
doaj +2 more sources
Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]
Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter+5 more
doaj +1 more source
The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review [PDF]
Metabolic syndrome (MetS), as a health-threatening factor, consists of various symptoms including insulin resistance, high blood sugar, hypertension, dyslipidemia, inflammation, and abdominal obesity that raise the risk of diabetes mellitus and ...
Roghayeh Yahyazadeh+4 more
doaj +1 more source
Fine structural changes in the hepatic microbodies of male adult rats treated with a newly developed hypolipidemic agent, gemfibrozil, were compared with results of clofibrate treatment.
Kuniaki Fukuda+3 more
openalex +3 more sources